Tech Company Financing Transactions
Expressable Funding Round
F-Prime Capital, Amplifyher Ventures and Lerer Hippeau participated in a $15 million Series A funding round for Expressable. This venture round was announced on 2/24/2022.
Transaction Overview
Company Name
Announced On
2/24/2022
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Proceeds Purpose
The money will be used to improve Expressable's technology and data platform, hire speech-language pathologists and partner with more providers and health plans.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
6218 Blarwood Dr.
Austin, TX 78745
USA
Austin, TX 78745
USA
Phone
Website
Email Address
Overview
Expressable is an online speech therapy practice committed to expanding access to quality services for everyone with a communication disorder. Expressable has pioneered a parent-focused care model that uses technology and education to integrate speech therapy techniques into children's daily lives, improving outcomes and experiences.
Management Team
Browse more venture capital transactions:
Prev: 2/24/2022: Indapta Therapeutics venture capital transaction
Next: 2/24/2022: GLO Pharma venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs